Page 15 - 《中国药房》2022年23期
P. 15

acting agents use:a systematic review and meta-analysis  ban  monotherapy  vs  combination  therapy  with  antiplate‐
              [J]. J Neurol Sci,2021,430:120009.                  lets on total thrombotic and bleeding events in atrial fibril‐
          [40]  SINGH  A,HUSSAIN  S,AKKALA  S,et  al.  Beta-      lation with stable coronary artery disease:a post hoc secon-
              adrenergic drugs and risk of Parkinson’s disease:a syste-   dary analysis of the AFIRE trial[J]. JAMA Cardiol,2022,
              matic review and meta-analysis[J]. Ageing Res Rev,2022,  7(8):787-794.
              80:101670.                                     [53]  李静,范利,华琦,等.中国老年高血压管理指南2019[J].
          [41]  国家卫生计生委合理用药专家委员会,中国药师协会 .                         中国心血管杂志,2019,24(1):1-23.
              冠心病合理用药指南:第2版[J/OL].中国医学前沿杂志                   [54]  国家卫生健康委办公厅.中国脑卒中防治指导规范:2021
              (电子版),2018,10(6):1-130[2022-11-01]. https://kns.    年版[EB/OL].(2021-08-27)[2022-11-01]. https://www.cn-
              cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&dbname=  healthcare.com/articlewm/20210903/content-1260368.html.
              CJFDLAST2018&filename=YXQY201806001&uniplat‐   [55]  NISHIO  S,WATANABE  H,KOSUGE  K,et  al.  Interac‐
              form=NZKPT&v=gXLJChLzUkupU3L15Dcsucf3rGLk-          tion between amlodipine and simvastatin in patients with
              Mm-gtF7R-seQfS0aZ4IJGltyrLG6o5acz6PZ.               hypercholesterolemia and hypertension[J]. Hypertens Res,
          [42]  PAZAN  F,GERCKE  Y,WEISS  C,et  al.  The  JAPAN-  2005,28(3):223-227.
              FORTA (fit  for  the  aged)  list:consensus  validation  of  a   [56]  WANG Y C,HSIEH T C,CHOU C L,et al. Risks of ad‐
              clinical  tool  to  improve  drug  therapy  in  older  adults[J].   verse  events  following  coprescription  of  statins  and  cal‐
              Arch Gerontol Geriatr,2020,91:104217.               cium  channel  blockers:a  nationwide  population-based
          [43]  ZIEGELSTEIN R C,MEUCHEL J,KIM T J,et al. Selec‐   study[J]. Medicine (Baltimore),2016,95(2):e2487.
              tive serotonin reuptake inhibitor use by patients with acute   [57]  WIGGINS B S,SASEEN J J,PAGE R L 2nd,et al. Re-
              coronary syndromes[J]. Am J Med,2007,120(6):525-530.  commendations  for  management  of  clinically  significant
          [44]  LABOS  C,DASGUPTA  K,NEDJAR  H,et  al.  Risk  of   drug-drug interactions with statins and select agents used
              bleeding associated with combined use of selective sero‐  in patients with cardiovascular disease:a scientific state‐
              tonin reuptake inhibitors and antiplatelet therapy following   ment from the American Heart Association[J]. Circulation,
              acute  myocardial  infarction[J].  J  De  L’association  Med   2016,134(21):e468-e495.
              Can,2011,183(16):1835-1843.                    [58]  WATANABE H,KOSUGE K,NISHIO S,et al. Pharmaco‐
          [45]  SCHELLEMAN H,BRENSINGER C M,BILKER W B,           kinetic and pharmacodynamic interactions between simva-
              et  al.  Antidepressant-warfarin  interaction  and  associated   statin and diltiazem in patients with hypercholesterolemia
              gastrointestinal  bleeding  risk  in  a  case-control  study[J].   and hypertension[J]. Life Sci,2004,76(3):281-292.
              PLoS One,2011,6(6):e21447.                     [59]  AZIE N E,BRATER D C,BECKER P A,et al. The inter-
          [46]  LÖPPÖNEN P,TETRI S,JUVELA S,et al. Association    action of diltiazem with lovastatin and pravastatin[J]. Clin
              between  warfarin  combined  with  serotonin-modulating    Pharmacol Ther,1998,64(4):369-377.
              antidepressants  and  increased  case  fatality  in  primary        [60]  CHOI D H,CHUNG J H,CHOI J S. Pharmacokinetic in‐
              intracerebral  hemorrhage:a  population-based  study[J].  J   teraction between oral lovastatin and verapamil in healthy
              Neurosurg,2014,120(6):1358-1363.                    subjects:role of P-glycoprotein inhibition by lovastatin[J].
          [47]  QUINN G R,SINGER D E,CHANG Y,et al. Effect of se‐  Eur J Clin Pharmacol,2010,66(3):285-290.
              lective serotonin reuptake inhibitors on bleeding risk in pa‐  [61]  BECQUEMONT  L,NEUVONEN  M,VERSTUYFT  C,
              tients with atrial fibrillation taking warfarin[J]. Am J Car‐  et al. Amiodarone interacts with simvastatin but not with
              diol,2014,114(4):583-586.                           pravastatin  disposition  kinetics[J].  Clin  Pharmacol  Ther,
          [48]  WALLERSTEDT S M,GLEERUP H,SUNDSTRÖM A,            2007,81(5):679-684.
              et  al.  Risk  of  clinically  relevant  bleeding  in  warfarin-  [62]  中国痴呆与认知障碍诊治指南写作组,中国医师协会神
              treated patients:influence of SSRI treatment[J]. Pharmaco‐  经内科医师分会认知障碍疾病专业委员会.2018中国痴
              epidemiol Drug Saf,2009,18(5):412-416.              呆与认知障碍诊治指南:十:痴呆精神行为症状鉴别诊
          [49]  COCHRAN K A,CAVALLARI L H,SHAPIRO N L,et al.      断和治疗[J].中华医学杂志,2020,100(17):1290-1293.
              Bleeding incidence with concomitant use of antidepressants   [63]  POTTIE  K,THOMPSON  W,DAVIES  S,et  al.  Depre‐
              and warfarin[J]. Ther Drug Monit,2011,33(4):433-438.  scribing benzodiazepine receptor agonists:evidence-based
          [50]  中华医学会,中华医学会杂志社,中华医学会全科医学                          clinical practice guideline[J]. Can Fam Physician,2018,64
              分会,等 . 缺血性卒中基层诊疗指南:2021 年[J]. 中华全                  (5):339-351.
              科医师杂志,2021,20(9):927-946.                      [64]  BACKMAN  J  T,OLKKOLA  K  T,ARANKO  K,et  al.
          [51]  中华医学会心电生理和起搏分会,中国医师协会心律学                          Dose  of  midazolam  should  be  reduced  during  diltiazem
              专业委员会,中国房颤中心联盟心房颤动防治专家工作                            and verapamil treatments[J]. Br J Clin Pharmacol,1994,
              委员会 . 心房颤动:目前的认识和治疗建议:2021[J]. 中                    37(3):221-225.
              华心律失常学杂志,2022,26(1):15-88.                                    (收稿日期:2022-11-11  修回日期:2022-11-17)
          [52]  NAITO  R,MIYAUCHI  K,YASUDA  S,et  al.  Rivaroxa‐                                 (编辑:刘明伟)



          中国药房  2022年第33卷第23期                                              China Pharmacy  2022 Vol. 33  No. 23    · 2825 ·
   10   11   12   13   14   15   16   17   18   19   20